Tomorrows FM


The latest for your laboratory science updates: lab news, innovations, products and more.

Partnership creates microfluidic kits

Published on 12/11/2020

Dolomite Microfluidics and MilliporeSigma have partnered to create a range of off-the-shelf NanoFabTx microfluidic device kits for producing PLGA nano- and microparticles for drug development and controlled drug release applications.


Invasive aspergillosis screening for COVID-19

Published on 11/11/2020

IMMY sõna Aspergillus Galactomannan Lateral Flow Assay has been recommended by the European Confederation of Medical Microbiology as a screening device in ventilated patients.


New appointments at Oxeltis

Published on 10/11/2020

Oxeltis has announced it has promoted Dr Stéphane Salamone to Director of Chemistry, and appointed Dr Olivier Lavergne as Consultant in Medical Chemistry.


Recombinant monoclonal antibody development

Published on 9/11/2020

AMSBIO has announced a new rabbit and mouse recombinant monoclonal antibody development service, based upon a revolutionary technology platform.


New fluorescence live-cell imager

Published on 6/11/2020

CytoSMART Technologies has announced the Lux3 FL, its first small fluorescence live-cell imaging microscope equipped with one brightfield and two fluorescent channels (green and red).


Ziath supports food poverty charity

Published on 5/11/2020

Ziath, manufacturers of imagers for reading 2D barcoded sample tubes, is supporting their local food bank charity in Cambridge, UK.


Automating reaction optimisation

Published on 4/11/2020

Uniqsis’ FlowSyn Multi-X takes the drudgery out of reaction optimisation, effortlessly converting batch chemistry methods to more efficient, higher-yielding flow chemistry protocols.


Digital clinical trials platform launched

Published on 2/11/2020

A Dublin-based tech start-up has announced the launch of Wirano, a digital platform for the rapid and effective organisation of clinical trials.


Clinical trial sites kept open

Published on 30/10/2020

Panthera has put in place measures to ensure clinical trials can continue safely for patients, staff and sponsors as COVID-19 continues to affect so many other areas of healthcare and society.


Affinity binding assay microplates

Published on 29/10/2020

Porvair Sciences say their new medium and high bind Krystal microplates set a new standard for uniform and reproducible capture of a wide range of biomolecules ready for affinity binding assays such as ELISA’s.


Twitter feed

Visit our other websites